Qube Research & Technologies (QRT)’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-92,795
Closed -$405K 3756
2025
Q4
$405K Buy
92,795
+55,571
+149% +$300K ﹤0.01% 2866
2025
Q3
$156K Buy
37,224
+18,734
+101% +$66.5K ﹤0.01% 2989
2025
Q2
$53.1K Sell
18,490
-10,592
-36% -$28K ﹤0.01% 3138
2025
Q1
$78.5K Buy
+29,082
New +$109K ﹤0.01% 3038
2024
Q4
Sell
-12,579
Closed -$29.8K 3596
2024
Q3
$29.8K Sell
12,579
-15,296
-55% -$33.7K ﹤0.01% 2933
2024
Q2
$54.4K Buy
+27,875
New +$94.7K ﹤0.01% 2729

Other funds holding GNLX

Qube Research & Technologies (QRT)'s GNLX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Genelux (GNLX) in Q1 2026, closing a stake of 92,795 shares — an estimated $405K sold.

Qube Research & Technologies (QRT) first reported a position in GNLX in Q2 2024 and held it in 6 quarters. The position peaked at $405K in Q4 2025. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Genelux position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 92,795 Genelux shares in Q1 2026, an estimated $405K.
  • Qube Research & Technologies (QRT) first reported a position in Genelux in Q2 2024 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Genelux position peaked at $405K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.